tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Jazz Pharmaceuticals reports Q3 adjusted EPS $8.13, consensus $5.85
PremiumThe FlyJazz Pharmaceuticals reports Q3 adjusted EPS $8.13, consensus $5.85
3d ago
Jazz Pharmaceuticals raises FY25 adj EPS view to $7.65-$8.45 from $4.80-$5.60
Premium
The Fly
Jazz Pharmaceuticals raises FY25 adj EPS view to $7.65-$8.45 from $4.80-$5.60
3d ago
JAZZ Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
JAZZ Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
Jazz Pharmaceuticals price target raised to $183 from $180 at Morgan Stanley
PremiumThe FlyJazz Pharmaceuticals price target raised to $183 from $180 at Morgan Stanley
15d ago
Jazz Pharmaceuticals: Buy Rating Affirmed Amid Legal Settlement and Strategic Stability
Premium
Ratings
Jazz Pharmaceuticals: Buy Rating Affirmed Amid Legal Settlement and Strategic Stability
16d ago
Jazz Pharmaceuticals Settles Disputes with Avadel
Premium
Company Announcements
Jazz Pharmaceuticals Settles Disputes with Avadel
17d ago
Jazz Pharmaceuticals Completes Study on Promising HER2 Cancer Treatment
PremiumCompany AnnouncementsJazz Pharmaceuticals Completes Study on Promising HER2 Cancer Treatment
23d ago
Jazz Pharmaceuticals price target raised to $230 from $225 at BofA
Premium
The Fly
Jazz Pharmaceuticals price target raised to $230 from $225 at BofA
1M ago
Jazz Pharmaceuticals announces FDA approves Zepzelca in ES-SCLC
Premium
The Fly
Jazz Pharmaceuticals announces FDA approves Zepzelca in ES-SCLC
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100